UNSPSC 51162340: Chlorpheniramine/methscopolamine/phenylephrine

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class RE500. This VA Drug Class (RE500) classifies this compound as belonging to the group COLD REMEDIES, COMBINATIONS.

UNSPSC 51162340 Chlorpheniramine/methscopolamine/phenylephrine is a Commodity code that encompasses pharmaceutical products and medical supply procurement by state and local health agencies and correctional departments. While the code's nominal designation reflects a specific antihistamine–anticholinergic–decongestant combination, recent state and local solicitations under this code actually reflect broader parenteral products and emergency pharmaceutical procurement — including intravenous solutions, parenteral nutrition formulations, naloxone kits, and drug deactivation systems. The issuing bodies include state departments of corrections and county health departments; both procurement types involve regulated pharmaceutical delivery with strict compliance, insurance, and performance-standard requirements.

The Washington State Department of Corrections posted RFQQK13020 on September 8, 2026 (response due October 7, 2026) to solicit parenteral products, services, and equipment for eight correctional facilities across three regions, with 24-hour delivery requirements for nutrition solutions and 8-hour delivery for other parenteral products; the RFQ encourages small business, minority-owned business, women-owned business, and veteran-owned business participation under Washington's Chapter 39.19 RCW with an aspirational 5% Small and Diverse Business Goal and anticipates awarding up to three contractors per region through November 26, 2026 to June 30, 2030. Seminole County, Florida posted IFB 60459723LAS on June 30, 2026 (response due July 26, 2026) for annual procurement of 1,900 units of naloxone and 800 safe drug deactivation systems with quarterly deliveries to Sanford; the procurement carries a two-year initial term with one-year renewal option and requires E-Verify compliance and fixed pricing. Recent activity centers on Washington state and Florida, with both opportunities reflecting public-sector pharmaceutical supply chains tied to health and safety mandates.